To view this email as a web page, click here.
September 5, 2019
 
ASRS 2019 Street Team recap: Rishi P. Singh, MD
image description here ICYMI: Rishi P. Singh, MD, discusses the results of a post hoc analysis between VISTA and VIVID, and the overall sustained diabetic retinopathy severity improvements with intravitreal aflibercept in diabetic macular edema.

Learn more
 
Greater IOP-lowering potential with iStent inject
image description here The number of glaucoma sufferers rises every year, as has the advent of new technology with which to treat this disease, according to Joseph Gira, MD.

Find out
 
Alcon debuts AcrySof IQ PanOptix trifocal IOL to U.S. market
image description here Alcon has received FDA approval for its AcrySof IQ PanOptix Trifocal IOL, and the company is rolling out its initial commercial launch of the product.

Continue
 
ADVERTISEMENT
Not just resources — a complete Provider Toolkit
Elevate your practice’s premium cataract experience with the latest solutions, strategies, and resources for surgical techniques, IOL advances, and pre- and postoperative care. Explore now.
 
RELATED ARTICLES
 
Three secrets to success for low myopes
Excellent visual outcomes achieved with novel trifocal design
(SLIDESHOW) 7 pediatric eye myths parents should stop believing
Dislocation and decentration remain common reasons for IOL removal
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.